๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Liver Cancer
Clinical trial register · China

Liver Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 8 Guangzhou 7 Chengdu 7 Shanghai 5 Wuhan 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
West China Hospital7 Second Affiliated Hospital of Guangzhou Medical University6 Sun Yat-sen University3 Anhui Provincial Hospital2 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
Site location
Beijing8 Guangzhou7 Chengdu7 Shanghai5 Wuhan3
All 31 locations
Target enrolment
to

Liver Cancer trials in China

38 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion
NCT07790419Liver Cancer
DrugsDonafenib·Apatinib·Lenvatinib·Tislelizumab
Zhai Wenlong
Phase 4
40
Zhengzhou
2026-08-30
Recruiting
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
NCT07763301Liver Cancer, Pancreatic Cancer, Biliary Tract Cancer (BTC)
DrugYMN-136 vaccine
West China Hospital
Phase 1
9
Chengdu
2026-08-01
Recruiting
China Metastatic Liver Cancer Clinical Registry Cohort Database
NCT07602504Liver Metastases, Metastases to Liver, Liver Cancer, Neoplasms
Anhui Provincial Hospital
Observational
2,000
Bengbu, Hefei, Qingdao
2026-06-01
Active, closed
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions
NCT07645209Liver Cancer
Harbin Medical University
Observational
1,000
Harbin
2026-05-13
Recruiting
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
NCT07295275Liver Cancer
West China Hospital
Observational
200
Beijing, Xuzhou, Chengdu
2026-03-01
Recruiting
Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection
NCT07295340Liver Cancer
West China Hospital
Observational
20
Chengdu
2026-01-01
Recruiting
Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer
NCT07325565Liver Cancer, Emotional Disorder
Tongji Hospital
Observational
651
Wuhan
2025-12-20
Active, closed
AI Multimodal Model for Liver Cancer Diagnosis and Prognosis
NCT07658586Liver Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma (Icc)
Guangxi Medical University
Observational
600
Nanning
2025-12-01
Recruiting
PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.
NCT07053072Liver Cancer
West China Hospital
Phase 1
9
Chengdu
2025-10-23
By invitation
The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol
NCT07537205Liver Cancer
Fudan University
Not applicable
92
Shanghai
2025-10-08
Active, closed
A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors
NCT07362264Liver Cancer
DrugSH006
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 1
50
Nanjing
2025-07-01
Recruiting
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
NCT07053488Liver Diseases, Liver Cancer, Liver Cirrhosis, Liver Failure
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2
90
Beijing
2025-06-01
Not yet open
The Application Value of Spectral CT in the Accurate Staging of Liver Cancer
NCT06977399Liver Cancer
Yunnan Cancer Hospital
Not applicable
150
Kunming
2025-06-01
Recruiting
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
NCT06950814Sarcomatoid Carcinoma, Liver Cancer, Adjuvant Therapy
West China Hospital
Observational
50
Chengdu
2025-04-05
Recruiting
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
NCT06873659Solid Tumor, Gastric Cancer, Liver Cancer
Qurgen Inc.
Phase 1
96
Beijing, Lanzhou, Guangzhou, Nanjing, Xi'an, Jinan, Shanghai, Hangzhou
2025-02-26
Not yet open
FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation
NCT06409637Liver Cancer, Liver Transplant
DrugLenvatinib
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2
62
Guangzhou
2025-01-01
Recruiting
China Liver Cancer Clinical Registry Cohort Database (HEAL)
NCT06777485Liver Cancer
Anhui Provincial Hospital
Observational
10,000
Anqing, Bengbu, Bozhou, Chizhou, Chuzhou, Fuyang, Hefei, Huaibei
2025-01-01
Recruiting
TACE Combined Surgery for the Resectable Huge HCC
NCT06898398Hepatocellular Carcinoma, Hepatic Chemotherapy, Liver Cancer, Surgery
Sun Yat-sen University
Observational
326
Beijing
2025-01-01
Not yet open
Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .
NCT06632522Liver Cancer
Beijing Tsinghua Chang Gung Hospital
Phase 2
46
Beijing
2024-10-20
Recruiting
DEB-TACE Prior to Liver Transplantation in the Treatment of HCC
NCT06353126Liver Cancer
RenJi Hospital
Phase 4
40
Shanghai
2024-10-16
Recruiting
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NCT06632886Lung Cancers, Liver Cancer, Gastric Cancers, Colorectal, Cancer
Guo ShiWei
Not applicable
1,000,000
Shanghai
2024-10-07
Recruiting
HAIC Compared With TACE in Huge Hepatocellular Carcinoma
NCT06641713Hepatocellular Carcinoma, Hepatic Chemotherapy, Liver Cancer
Sun Yat-sen University
Observational
664
Beijing
2024-10-01
Recruiting
Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach๏ผˆRadiogenomics-Liver๏ผ‰
NCT06536998Liver Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
150
Wuhan
2024-08
Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer
NCT07356531Liver Cancer
JIANGSU SHENMING Medical Technology CO., Ltd
Not applicable
216
Hefei, Beijing, Nanning, Guiyang, Shijiazhuang, Anyang, Luoyang, Zhengzhou
2024-07-29
Recruiting
Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT
NCT06482801Liver Cancer, Antibody
DrugsDurvalumab, idarubicin, bevacizumab·Ipilimumab·Pembrolizumab
Second Affiliated Hospital of Guangzhou Medical University
Phase 2
90
Guangzhou
2024-06-10
Recruiting
GPC3/Mesothelin-CAR-ฮณฮดT Cells Against Cancers
NCT06196294Pancreas Cancer, Lung Cancer, Liver Cancer, Mesothelioma
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2024-05-10
Recruiting
Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
NCT06341270Liver Cancer
West China Hospital
Not applicable
524
Chengdu
2024-05-06
Recruiting
Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy
NCT06406244Liver Cancer
West China Hospital
Not applicable
524
Chengdu
2024-04-20
Recruiting
Interventional Software for Multi-immunotherapy of Solid Tumors
NCT06478108Lung Cancer, Liver Cancer, Solid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3
60
Guangzhou
2024-04-01
Recruiting
Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC
NCT06251115Liver Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
9
Shanghai
2024-01-26
Not yet open
Effects of CBT-Based Intervention Among Patients With Liver Cancer
NCT05942560Depression, Anxiety, Liver Cancer, CBT
The Nethersole School of Nursing
Not applicable
160
Zhuhai
2023-12-30
Recruiting
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
NCT06139042Liver Cancer, Biliary Tract Cancer, Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,608
Hangzhou
2023-11-01
Recruiting
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
NCT05444478Hepatocellular Carcinoma, Microwave Ablation, Liver Cancer, Lenvatinib
Sun Yat-sen University
Not applicable
274
Changsha
2022-07-01
Recruiting
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
NCT05187338Lung Cancer, Liver Cancer, Colorectal Cancer, Pancreas Cancer
DrugsIpilimumab·Durvalumab·Pembrolizumab
Second Affiliated Hospital of Guangzhou Medical University
Phase 1/2
100
Guangzhou
2021-11-01
Recruiting
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
NCT04842812Liver Cancer, Lung Cancer, Breast Cancer, Colo-rectal Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
40
Guangzhou
2021-01-01
Recruiting
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer
NCT06084299Liver Cancer
DrugAutologous Tumor Infiltrating Lymphocytes
Zhiyong Huang
Phase 1
16
Wuhan
2020-05-27
Recruiting
Effect and Mechanism of ALPPS Operation on Liver Regeneration
NCT07142213Hepato Cellular Carcinoma (HCC), Hepatobiliary Cancers, Liver Cancer, Liver Regeneration
Haitao Zhao, MD
Observational
50
Beijing
2020-01-01
Recruiting
Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma
NCT03949231Liver Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 3
200
Guanzhou
2019-01-01
Rows per page Showing 1–38 of 38
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/liver-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 38 of those studies listing the condition Liver Cancer.

How many Liver Cancer trials are recruiting in China?

29 of the 38 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 5 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Liver Cancer), 38 studies
PhaseStudiesRecruitingShare
Observational131134.2%
Not applicable9623.7%
Phase 17618.4%
Phase 1/2327.9%
Phase 2215.3%
Phase 4215.3%
Phase 2/3112.6%
Phase 3112.6%

Most active sponsors

Lead sponsors with the most studies (Liver Cancer)
Lead sponsorStudiesRecruiting
West China Hospital77
Second Affiliated Hospital of Guangzhou Medical University66
Sun Yat-sen University33
Anhui Provincial Hospital22
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC11
Beijing Tsinghua Chang Gung Hospital10
Fudan University10
Guangxi Medical University10
Guo ShiWei11
Haitao Zhao, MD11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.